Dahu Health Industry Co., Ltd. Class A

Dahu Health Industry Co., Ltd. Class A

SSSE:600257
4.68
CNY
-0.07
(-1.47%)
0.12EPS
106.01P/E
2.65BMarket Cap

Total Valuation

CNY

As of September 30, 2026, Dahu Health Industry Co., Ltd. Class A carries a market capitalization of 2.65B, placing it among publicly traded companies globally. Its enterprise value stands at 3.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.65B
Enterprise Value3.14B

Share Statistics

As of September 30, 2026, Dahu Health Industry Co., Ltd. Class A has 481.24M shares outstanding.

Shares Outstanding481.24M

Valuation Ratios

As of September 30, 2026, Dahu Health Industry Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 106.01. The price-to-sales ratio is 2.91, and the price-to-book ratio stands at 3.23.

PE Ratio106.01
PS Ratio2.91
PB Ratio3.23
P/TBV Ratio4.62

Enterprise Valuation

As of September 30, 2026, Dahu Health Industry Co., Ltd. Class A trades at an EV/EBITDA multiple of 33.55 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.43 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 33.55 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.14B versus a market cap of 2.65B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales3.43
EV / EBITDA33.55
EV / EBIT33.55

Financial Position

As of September 30, 2026, Dahu Health Industry Co., Ltd. Class A maintains a current ratio of 2.49, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 73.04, indicating elevated leverage, while an interest coverage ratio of 3.30 demonstrates adequate ability to service its debt obligations.

Current Ratio2.49
Quick Ratio0.97
Debt / Equity73.04
Debt / EBITDA7.50
Interest Coverage3.30

Financial Efficiency

CNY

These figures cover the twelve months ended September 30, 2026. The company generates approximately 555,193.61 in revenue per employee across its workforce of 1,647.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee555,193.61
Employee Count1,647.00

Taxes

CNY

Over the twelve months ended September 30, 2026, Dahu Health Industry Co., Ltd. Class A recorded 32.26M in income tax expense. That works out to an effective tax rate of 35.14, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 91.81M, leaving 25.08M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax32.26M
Effective Tax Rate35.14

Stock Price Statistics

CNY

As of the close on November 17, 2026, Dahu Health Industry Co., Ltd. Class A's stock has declined approximately 26.65% over the past 52 weeks. The 50-day moving average sits at 5.28, while the 200-day moving average is 5.78.

52-Week Price Change-26.65%
50-Day Moving Average5.28
200-Day Moving Average5.78

Income Statement

CNY

Over the twelve months ended September 30, 2026, Dahu Health Industry Co., Ltd. Class A generated 914.40M in revenue and converted that into 25.08M in net income, yielding earnings per share of 0.12. EBITDA reached 93.61M, while operating income came in at 114.08M.

Revenue914.40M
Gross Profit281.69M
Operating Income114.08M
Pretax Income91.81M
Net Income25.08M
EBITDA93.61M
EBIT93.61M
Earnings Per Share (EPS)0.12

Balance Sheet

CNY

As of September 30, 2026, Dahu Health Industry Co., Ltd. Class A holds 352.33M in cash and equivalents against 702.53M in total debt, resulting in a net debt position of 51.77M. Total book value stands at 818.56M, with working capital of 540.73M providing operational flexibility.

Cash & Cash Equivalents352.33M
Total Debt702.53M
Net Debt51.77M
Equity (Book Value)818.56M
Book Value Per Share1.70
Working Capital540.73M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-54.98M

Margins

Over the twelve months ended September 30, 2026, Dahu Health Industry Co., Ltd. Class A posted a gross margin of 30.81, reflecting its pricing power and cost economics. The operating margin of 12.48 and net profit margin of 2.74 provide insight into operational efficiency.

Gross Margin30.81
Operating Margin12.48
Pretax Margin10.04
Profit Margin2.74
EBITDA Margin10.24

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Dahu Health Industry Co., Ltd. Class A paid dividends of 0.02 per share. The dividend payout ratio of 10.21 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 3.77, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Dahu Health Industry Co., Ltd. Class A shareholders.

Dividend Per Share0.02
Payout Ratio10.21
Shareholder Yield3.77

Stock Splits

Dahu Health Industry Co., Ltd. Class A's most recent stock split took place on May 19, 2008 with a 2:3 split ratio.

Last Split Date5/19/2008
Split Ratio2:3

Scores

As of September 30, 2026, Dahu Health Industry Co., Ltd. Class A has an Altman Z-Score of 2.88, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.88